Other DC-based vaccines that have been tested in the last decade in PC patients are prostate-specific membrane antigen (PSMA) and the survivin-loaded DC vaccine, mucin 1 (MUC1) vaccine, and the T cell receptor ɣ alternate reading frame protein (TARP) vaccine [149,150,151,152]. Here, MUC1 is linked to pachyonychia congenita.